ENTITY
Shandong Xinhua Pharmaceutical

Shandong Xinhua Pharmaceutical (719 HK)

114
Analysis
Health Care • China
Shandong Xinhua Pharmaceutical is a Chinese company specializing in the development, production, and distribution of chemical bulk drugs, pharmaceutical preparations, and medical intermediates. It is a leading global manufacturer and exporter of antipyretics and analgesics, as well as drugs for the central nervous system, steroids, and cardio cerebrovascular system. The company was established in 1943 and is headquartered in Zibo, Shandong, China.
more
•23 Jul 2023 10:05

A-H Premium Weekly (Jul 21st): China Vanke, New China Life, BYD, CMOC, Asymchem, Huaneng

We analyzed A-H premium changes in the past week and highlight A-H premium changes for  China Vanke, New China Life, BYD, CMOC, Asymchem, Huaneng,...

Logo
642 Views
Share
•16 Jul 2023 10:10

A-H Premium Weekly (Jul 14th): 52 Week High A-H for Banks

We analyzed A-H premium changes in the past week and highlight A-H premium changes for BankComm, ICBC, ABC, CCB, Remegen.

Logo
453 Views
Share
•09 Jul 2023 10:10

A-H Premium Weekly (Jul 7th): BankComm, ICBC, CCB, BYD, Asymchem, Hisense, Baiyunshan

We analyzed A-H premium changes in the past week and highlight A-H premium changes for  BankComm, ICBC, CCB, BYD, Asymchem, Hisense, Baiyunshan,...

Logo
709 Views
Share
•02 Jul 2023 10:05

A-H Premium Weekly (Jun 30th): Healthcare Led Premium Decline

We analyzed A-H premium changes in the past week and highlight A-H premium changes for Tianqi Lithium, CQRC Bank, Shanghai Fudan, Joinn Lab,...

Logo
393 Views
Share
•25 Jun 2023 10:05

A-H Premium Weekly (Jun 23rd): BYD, CMOC, China Southern, Cansino Biologics, Xinjiang Gold

We analyzed A-H premium changes in the past week and highlight A-H premium changes for  BYD, CMOC, China Southern, Cansino Biologics, Xinjiang Gold.

Logo
630 Views
Share
x